The Audit Committee is chaired by Charles Fairbairn and its other members are Steve Baldwin and Daniel King.
The Audit Committee is expected to meet formally at least four times a year and otherwise as required. It has responsibility for ensuring that the financial performance of the Company is properly reported on and reviewed, and its role includes monitoring the integrity of the financial statements of the Company (including annual and interim accounts and results announcements), reviewing internal control and risk management systems, reviewing any changes to accounting policies, reviewing and monitoring the extent of the non-audit services undertaken by external auditors and advising on the appointment of external auditors. In addition, under the Companies Law, the Audit Committee is required to monitor deficiencies in the administration of the Company, including by consulting with the internal auditor and independent accountants, to review, classify and approve related party transactions and extraordinary transactions, to review the internal auditor's audit plan and to establish and monitor whistle-blower procedures.
The Remuneration Committee is chaired by Daniel King and its other members are Steve Baldwin and Charles Fairbairn.
The Remuneration Committee is expected to meet not less than twice a year and at such other times as required. The Remuneration Committee has responsibility for determining, within the agreed terms of reference, the Group's policy on the remuneration packages of the Company's Chief Executive Officer, the Chairman of the Board, the executive and non-executive directors, the Company Secretary and other senior executives. The Remuneration Committee also has responsibility for: (i) approving and recommending to the Board and the Company's shareholders, the total individual remuneration package of the Chairman of the Board, each executive and non-executive director and the Chief Executive Officer (including bonuses, incentive payments and share options or other share awards); and (ii) approving and recommending to the Board the total individual remuneration package of the Company Secretary and all other senior executives (including bonuses, incentive payments and share options or other share awards), in each case within the terms of the Company's policy and in consultation with the Chairman of the Board and/or the Chief Executive Officer. No director or manager may be involved in any discussions as to their own remuneration.
The Nomination Committee is chaired by Daniel King and its other members are Gal Haber and Charles Fairbairn.
The Nomination Committee is expected to meet not less than twice a year and at such other times as required. The Nomination Committee has responsibility for reviewing the structure, size and composition (including the skills, knowledge and experience) of the Board, and giving full consideration to succession planning. It also has responsibility for recommending new appointments to the Board.
The Regulatory and Risk Committee is chaired by Penelope Judd and its other members are Charles Fairbairn, Elad Even-Chen and Asaf Elimelech.
The Regulatory and Risk Committee is expected to meet not less than twice a year and otherwise as required. The Regulatory & Risk Committee has responsibility for reviewing relationships with the regulatory authorities and reviewing the adequacy and quality of the Group’s systems and procedures for compliance with regulatory requirements where the Group is regulated and in other jurisdictions where the Group has a significant presence. The Regulatory and Risk Committee also has responsibility for reviewing the Company’s most significant risks to the achievement of strategic objectives, review the Company’s risk policy, ensure that the Company’s board ethics are being adhered to and the Company continues its commitment to issues concerning social responsibility. The type of most significant risks and uncertainties are outlined herein.
The Disclosure Committee is chaired by Elad Even-Chen and its other members are Charles Fairbairn and Asaf Elimelech.
The Disclosure Committee has responsibility for assisting the Board in fulfilling its responsibilities in respect of the requirement to make timely and accurate disclosure of all information that is required to be disclosed to
meet legal and regulatory obligations and requirements arising under the Market Abuse Regulation.